Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Amazon Announces Per-Second Billing For EC2 Instances And EBS Volumes

    AWS Blog | Amazon has announced that, effective October 2, usage of Linux instances that are launched in On-Demand, Reserved, and Spot form will be billed in one-second increments. Similarly, provisioned storage for EBS volumes will be billed in one-second increments. Per-second billing also applies to Amazon EMR and AWS Batch.

    Sep 18, 2017
  • Earlham Institute Presents Sequence Alignment Using Optalysys’ Optical Correlator Computing System

    Bio-IT World | 2017 Best Practices Awards | The Earlham Institute are working with Optalysys to apply Optalysys’ optical computing system to life science applications. The first release of the computing system is scheduled for early 2018, which both organizations say will be capable of performing a number of different DNA-based local sequence alignment applications.

    Sep 18, 2017
  • Moderna Ends “Venture” Experiment, Dissolves Four Startups

    Xconomy | Moderna Therapeutics announced today that it is ending the experiment to hatch startups as wholly-owned subsidaries, bringing all their experimental drugs back into the Moderna nest.

    Sep 14, 2017
  • Brainin Joins WuXi NextCODE, Prioritizes Actionability Of Genome

    Bio-IT World | WuXi NextCODE today announced the appointment of Rob Brainin as executive vice president and chief operating officer. Brainin joins the company from Illumina, where he was vice president and general manager of life sciences and applied genomics.

    Sep 13, 2017
  • IBM Expands Certified Public Cloud Infrastructure For SAP HANA

    Bio-IT World Brief | IBM today announced the availability of new SAP-certified bare metal servers for SAP HANA platform deployments in the IBM Cloud and new configurations for VMware environments. The new cloud infrastructure-as-a-service solutions are designed to give enterprises the power and performance they need to manage their mission-critical applications running on SAP HANA.

    Sep 12, 2017
  • Alexion Cutting 600 Jobs And Moving Headquarters In Major Shakeup

    STAT | Alexion, once one of biotech's biggest success stories, is eliminating 20% of its global workforce as it struggles to map out a brighter future.

    Sep 12, 2017
  • Long-Read Sequencing Data Enables Structural Variant Discovery For Clinical And Disease Research

    Bio-IT World Contributed Commentary | The advent of single molecule, real-time sequencing, with average read lengths exceeding 12 kb, has allowed scientists to reliably detect structural variation for the first time. These latest studies have shown that previous human genome data sets have dramatically underrepresented the number of structural variants—along with their effect on health and disease.

    Sep 11, 2017
  • Amid Setback Researchers Forge Ahead with “Off-the-Shelf” Immune Cells to Treat Cancer

    MIT Technology Review | The approach could treat patients in dire need faster at a lower price, but major questions remain about safety.

    Sep 8, 2017
  • Patients Without Traditional Cancer Screening Find Allies In Maccabi And Medial EarlySign

    Bio-IT World | 2017 Best Practices Awards | Maccabi Healthcare System is using Medial EarlySign’s clinical decision support tool to find colon cancer patients among individuals who didn’t go through traditional channels for screening.

    Sep 8, 2017
  • Does Your Genome Predict Your Face? Not Quite Yet

    MIT Technology Review | Genomics pioneer J. Craig Venter says if he had your genome he could pick you out of a crowd. According to two experts who reviewed the famed genomics expert's claim, however, that's not necessarily true.

    Sep 7, 2017
  • At Vanderbilt, NCI’s Cooperative Human Tissue Network Relies On Lean Principles For Efficiency

    Bio-IT World | The National Cancer Institute’s Cooperative Human Tissue Network (CHTN) provides human tissues and fluids from routine procedures to investigators who use human biospecimens in their research. Unlike tissue banks, the CHTN works prospectively with each investigator to tailor specimen acquisition and processing to meet their specific project requirements.

    Sep 7, 2017
  • IBM Pitched Watson As A Revolution In Cancer Care. It's Nowhere Close

    STAT | Three years after IBM began selling Watson for Oncology to recommend cancer treatments, it's falling short of the lofty expectations IBM created for it.

    Sep 6, 2017
  • Human Longevity Researchers Use Whole Genome Sequence Data And Machine Learning To Identify Individuals Through Face And Other Physical Trait Prediction

    Bio-IT World Brief | Researchers from Human Longevity have published a study in which individual faces and other physical traits were predicted using whole genome sequencing data and machine learning. This work was published in the journal Proceedings from the National Academy of Sciences.

    Sep 5, 2017
  • GenePattern Notebook Environment Needs Only A Web Browser To Run Analyses

    Bio-IT World Researchers at the University of California San Diego School of Medicine and the Broad Institute of MIT and Harvard have launched a new GenePattern Notebook environment, which combines the dynamic capabilities of an electronic analysis notebook with the ease of use of a point-and-click interface to hundreds of genomic tools.

    Aug 31, 2017
  • Renewed Attention Sees New Progress For Hepatitis B

    Bio-IT World | The HBV field has seen increased attention from industry research in the past few years, influenced by the success of new hepatitis C virus (HCV) therapies. After scientists realized HCV could be cured, they turned their attention to hepatitis B, hoping to develop a cure for it also.

    Aug 31, 2017
  • FDA Approval Brings First Gene Therapy To The United States

    Bio-IT World Brief | The U.S. Food and Drug Administration issued a historic action today making the first gene therapy available in the United States, ushering in a new approach to the treatment of cancer and other serious and life-threatening diseases.

    Aug 30, 2017
  • Edico, DNAnexus Launch $20, 90-minute Whole Genome Analysis

    Bio-IT World Edico Genome and DNAnexus, Inc. today announced the availability of Edico Genome’s DRAGEN on Amazon Web Service’s EC2 F1/FPGA instances via DNAnexus. For a limited time, the cost to analyze a whole genome at 35X coverage will be $20 and take about an hour and a half, Pieter van Rooyen said.

    Aug 30, 2017
  • Seven Bridges, Numerate, The Wellcome Trust Sanger Institute, And More: News From August 2017

    Bio-IT World | August featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Seven Bridges, Numerate, the Wellcome Trust Sanger Institute, and more.

    Aug 30, 2017
  • Freenome Announces Series A Extension Led By Section 32

    Diagnostics World News | Freenome announced that it has raised an additional $7 million as an extension to its previously announced Series A funding, bringing the total to nearly $72 million. The extension was led by Section 32.

    Aug 28, 2017
  • Gilead Agrees To Buy Kite Pharma, Leaping Into CAR-T Cancer Therapy

    STAT | Gilead agrees to buy Kite Pharma and its emerging line of CAR-T oncology therapies, which aim to harnesses the immune system to fight cancer.

    Aug 28, 2017
  • «
  • 71
  • 72
  • 73 (current)
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy